Document Detail


Genetics of familial combined hyperlipidemia.
MedLine Citation:
PMID:  11122695     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Complex disorders are caused by several environmental factors that interact with multiple genes. These diseases are common at the population level and constitute a major health problem in Western societies. Familial combined hyperlipidemia (FCHL) is characterized by elevated levels of serum total cholesterol, triglycerides, or both. This disorder is estimated to be common in Western populations with a prevalence of 1% to 2%. In addition, 14% of patients with premature coronary heart disease (CHD) have FCHL, making this disorder one of the most common genetic dyslipidemias underlying premature CHD. Both genetic and environmental factors are suggested to affect the complex FCHL phenotype, but no specific susceptibility genes to FCHL have been identified. It is hoped that further analysis of the first FCHL locus and other new loci obtained in genome-wide scans will guide us to genes predisposing to this complex disorder.
Authors:
P Pajukanta; K V Porkka
Related Documents :
10612815 - Mutation nomenclature extensions and suggestions to describe complex mutations: a discu...
17485295 - Genetics of endometriosis: current status and prospects.
11258195 - Genomics and large scale phenotypic databases.
17332845 - Meta-analysis in genome-wide association datasets: strategies and application in parkin...
21077125 - Genetics of ulcerative colitis.
25184405 - Subclinical psychotic experiences in healthy young adults: associations with stress and...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  1     ISSN:  1523-3804     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  1999 Jul 
Date Detail:
Created Date:  2001-01-26     Completed Date:  2001-07-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  79-86     Citation Subset:  IM    
Affiliation:
University of California, Los Angeles, Department of Human Genetics, Los Angeles, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoprotein A-I / genetics
Chromosome Mapping
Coronary Disease / etiology,  genetics
Genetic Predisposition to Disease
Humans
Hyperlipidemia, Familial Combined / complications,  genetics*
Linkage (Genetics)
Lipoprotein Lipase / genetics
Chemical
Reg. No./Substance:
0/Apolipoprotein A-I; EC 3.1.1.34/Lipoprotein Lipase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Common mutations of the lipoprotein lipase gene and their clinical significance.
Next Document:  Genetic markers to predict polygenic disease.